cadth powerpoint templatecommonly requested products the f ol l ow i ng t abl e pr ov i des br i ef...
TRANSCRIPT
![Page 1: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/1.jpg)
![Page 2: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/2.jpg)
HEALTH PEI VALUES Caring We treat everyone with compassion, respect, fairness, and dignity Integrity We collaborate in an environment of trust, communicate with openness and honesty, and are accountable through responsible decision-making Excellence We pursue continuous quality improvement through innovation, integration, and the adoption of evidence-based practices
![Page 3: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/3.jpg)
WHY DOES URINE MATTER TO YOU?
Introduce yourself to your colleagues and share…..
![Page 4: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/4.jpg)
Objectives: - HOW DID WE GET HERE? - LIAISON PROGRAM - CADTH PRODUCTS - EVIDENCE INFORMED DECISIONS - URINE MATTERS #URINE MATTERS- TWITTER
![Page 5: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/5.jpg)
CADTH is a health technology assessment
agency
We inform technology-related decision-making
in health care
![Page 6: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/6.jpg)
How did we get here?
![Page 7: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/7.jpg)
CADTH’S VISION
HEALTH TECHNOLOGY ASSESSMENT INFORMS EVERY HEALTH TECHNOLOGY DECISION.
![Page 8: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/8.jpg)
CADTH’S MISSION TO ENHANCE THE HEALTH OF CANADIANS BY PROMOTING THE OPTIMAL USE OF HEALTH TECHNOLOGIES.
![Page 9: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/9.jpg)
![Page 10: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/10.jpg)
KNOWLEDGE SHARING: A CADTH SERVICE
![Page 11: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/11.jpg)
Evidence Informed Decision Making
.
![Page 12: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/12.jpg)
Commonly Requested Products The following table provides brief descriptions of the products CADTH most commonly produces in response to requests, as well as approximate completion times.
Product Type Description* Approximate turnaround time from point of topic refinement**
Reference list List of the best available evidence with abstracts and links to full-text documents, if available.
5 to 10 business days
Summary of abstracts Summary based on the abstracts of the best available evidence. Includes the abstracts and
links to full-text documents, if available.
15 business days
Summary with critical appraisal Written summary of the evidence from full text
articles, with a critical appraisal and policy implications.
30 business days
Peer-reviewed summary with critical appraisal
Summary of systematically selected evidence with a critical appraisal and policy implications. An
external peer-review is conducted.
Four months
Systematic review and meta-
analysis
A systematic review of the evidence and a meta-
analysis is performed, where appropriate. Authorship includes a content expert, and an
external peer-review is conducted.
4 to 5 months
Rapid health technology
assessment
A systematic review of clinical studies and an
economic component that includes a systematic
review of economic studies, an economic evaluation or a budget impact analysis. It excludes
a review of the health services impact. Authorship includes a content expert, and an external peer-
review is conducted.
5 to 6 months
Environmental Scan Scan of innovative technologies or pan-Canadian
access, reimbursement, or practice issues.
5 to 40 business days
Drug review and formulary
recommendation
Rigorous review of the clinical and cost-
effectiveness of a drug, and a formulary listing recommendation for Canada’s publicly funded
drug plans (excluding Quebec) through CADTH’s Common Drug Review process. Typically,
submissions are received from drug manufacturers; however, the CDR-participating
drug plans may also request a CDR review.
5 to 6 months
Health technology assessment Comprehensive, evidence-based analysis of a
health technology or technologies to support and inform decisions about health policy, purchasing,
service management, and clinical practice. May
include a systematic review of clinical evidence, a systematic review of cost-effectiveness, and
information on the broader impact on patient health and the health care system.
Determined on a case-by-case basis
Optimal use project Project designed to encourage the optimal use of a health technology or technologies by health care
providers, policy-makers, and consumers. May include a systematic review of clinical evidence, a
systematic review of cost-effectiveness, and development of recommendations, supporting
documents, and tools.
Determined on a case-by-case basis
*These products may be tailored to meet the needs and timelines of the requestor and are subject to the
quality and quantity of the published literature.
**The turnaround times are subject to the capacity and ongoing projects at CADTH. Timelines will be
negotiated between a CADTH representative and the requestor at the time of topic refinement.
![Page 13: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/13.jpg)
RAPID RESPONSE • DRUGS
• DIAGNOSTICS
• DEVICES
• SURGICAL AND MEDICAL PROCEDURES
![Page 14: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/14.jpg)
Collaboration.
PARTNERSHIPS REQUIRED.
![Page 15: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/15.jpg)
CADTH ROADSHOW. PANCANADIAN PERSPECTIVES
![Page 16: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/16.jpg)
LAB UTILIZATION-A CADTH ROADSHOW
![Page 17: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/17.jpg)
SAVE THE DATE! Sharing the results.
March 23, 2015 National Webinar
![Page 18: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/18.jpg)
Urine Matters.
UTI CARE PATHWAYS FOR ENHANCED COLLABORATION & ANTIBIOTIC SAFETY IN SENIORS.
![Page 19: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/19.jpg)
Interior Slide
Contributing to the conversation about laboratory test optimization and encouraging it to continue.
![Page 20: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/20.jpg)
What does the evidence say?
![Page 21: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/21.jpg)
Clinical and Cost Effectiveness 1. What is the clinical effectiveness of urine cultures
and sensitivity analysis, urine dipstick testing, or urinalysis for urine testing in asymptomatic residents in long term-care?
2. What is the cost effectiveness of urine cultures and sensitivity analysis, urine dipstick testing, or urinalysis for urine testing in asymptomatic residents in long-term care?
20
![Page 22: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/22.jpg)
Evidence-based Guidelines 3. What are the evidence-based guidelines regarding
the ordering of urine cultures and sensitivity tests, dipstick tests, and urinalysis for residents in long-term care?
4. What are the evidence-based guidelines regarding proper collection of urine for urine testing in long-term care residents?
5. What are the evidence-based guidelines regarding the interpretation of urine test results?
21
![Page 23: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/23.jpg)
WHAT DOES THE EVIDENCE SAY?
6. What is the clinical evidence on the development of antibiotic resistance to norfloxaxin in treatment of urinary tract infections (UTIs)?
7. What is the clinical evidence regarding the
safety of nitrfurantoin in elderly males with urinary tract infections?
![Page 24: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/24.jpg)
What does the evidence say?
8.What is the comparative clinical effectiveness of long-term antibiotic prophylaxis and treatment of urinary tract infections (UTIs) in the elderly?
9.What are the evidence-based guidelines
regarding the management of UTIs with antibiotics in the elderly?
![Page 25: CADTH Powerpoint TemplateCommonly Requested Products The f ol l ow i ng t abl e pr ov i des br i ef des c r i pt i ons of t he pr oduc t s C ADTH m ost c om m onl y pr oduc es i n](https://reader033.vdocument.in/reader033/viewer/2022041607/5e34c99663bc481d555a2e7b/html5/thumbnails/25.jpg)